Endres H, Dayan D, Ebner F, Huwer S, Jakob D, Medl M, Yagcioglu L, Juhasz-Boess I, Taran F A, Jung L
Department of Obstetrics and Gynecology, University Medical Center Freiburg, Freiburg, Germany.
Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
Arch Gynecol Obstet. 2025 Sep 10. doi: 10.1007/s00404-025-08173-6.
To investigate the clinical utility of diagnostic laparoscopy in guiding treatment strategy and surgical outcomes for patients with advanced-stage ovarian cancer, specifically regarding operability assessment and the likelihood of complete cytoreduction.
This retrospective cohort study analyzed 183 patients with histologically confirmed International Federation of Gynecology and Obstetrics (FIGO) stage III-IV ovarian cancer treated with curative intent between January 2018 and December 2023 at a tertiary referral center. Patients were divided into two groups: those who underwent diagnostic laparoscopy prior to primary treatment (n = 80) and those managed without laparoscopy (n = 103). Laparoscopy was selectively employed when operability was uncertain. The primary outcome was the rate of complete macroscopic tumor resection. Secondary endpoints included intraoperative inoperability, neoadjuvant chemotherapy (NACT) rates, and surgical complexity. Statistical analyses included chi-square tests and predictive value calculations.
Complete macroscopic resection was achieved in 57.5% of patients in the laparoscopy group compared to 68.0% in the control group. Among FIGO III cases, complete resection was lower in the laparoscopy group (63.0% vs. 77.0%), while rates were similar for FIGO IV (53.8% vs. 54.8%). Diagnostic laparoscopy had a positive predictive value of 59% and was a statistically significant, albeit weak, predictor of operability (p = 0.003, phi = 0.13). Patients in the laparoscopy group were more frequently triaged to NACT (78.8% vs. 50.5%). Intraoperative inoperability was also higher (29% vs. 14%).
Diagnostic laparoscopy influenced treatment strategy by increasing NACT use and reducing non-beneficial surgeries. Though it did not improve overall cytoreduction rates, it enabled personalized treatment planning, especially in patients with ambiguous resectability, thereby potentially lowering surgical morbidity.
探讨诊断性腹腔镜检查在指导晚期卵巢癌患者治疗策略及手术结局方面的临床应用价值,特别是在可切除性评估及完全肿瘤细胞减灭可能性方面。
这项回顾性队列研究分析了2018年1月至2023年12月在一家三级转诊中心接受根治性治疗的183例经组织学确诊为国际妇产科联盟(FIGO)III-IV期卵巢癌的患者。患者分为两组:在初次治疗前行诊断性腹腔镜检查的患者(n = 80)和未行腹腔镜检查的患者(n = 103)。当可切除性不确定时选择性使用腹腔镜检查。主要结局是宏观肿瘤完全切除率。次要终点包括术中不可切除性、新辅助化疗(NACT)率和手术复杂性。统计分析包括卡方检验和预测值计算。
腹腔镜检查组57.5%的患者实现了宏观完全切除,而对照组为68.0%。在FIGO III期病例中,腹腔镜检查组的完全切除率较低(63.0%对77.0%),而FIGO IV期的比率相似(53.8%对54.8%)。诊断性腹腔镜检查的阳性预测值为59%,是可切除性的一个具有统计学意义(尽管较弱)的预测指标(p = 0.003,phi = 0.13)。腹腔镜检查组的患者更频繁地接受NACT治疗(78.8%对50.5%)。术中不可切除性也更高(29%对14%)。
诊断性腹腔镜检查通过增加NACT的使用和减少无益手术来影响治疗策略。虽然它没有提高总体肿瘤细胞减灭率,但它能够实现个性化治疗计划,特别是在可切除性不明确的患者中,从而可能降低手术发病率。